Simeng Gu
Impact in
-
- Cancer-related molecular mechanisms research
-
- Endometrial and Cervical Cancer Treatments
Papers in
-
- RNA modifications and cancer 5
- Cancer-related gene regulation 4
- RNA Research and Splicing 3
- Epigenetics and DNA Methylation 2
-
- Thyroid Disorders and Treatments 8
- Thyroid Cancer Diagnosis and Treatment 5
- Co-authors
- Mingjuan Jin (9 shared papers)Jianbing Wang (4 shared papers)Kun Chen (4 shared papers)Fangyuan Jing (4 shared papers)Kun Chen (5 shared papers)Yingjun Li (2 shared papers)Chunhong Fan (1 shared paper)Qilong Li (6 shared papers)
In The Last Decade
Simeng Gu
24 papers receiving 271 citations
Peers
Comparison fields: 5 of 70
- Cancer Research 80
- Obstetrics and Gynecology 30
- Epidemiology 75
- Oncology 53
- Molecular Biology 114
Countries citing papers authored by Simeng Gu
This map shows the geographic impact of Simeng Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simeng Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simeng Gu more than expected).
Fields of papers citing papers by Simeng Gu
This network shows the impact of papers produced by Simeng Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simeng Gu. The network helps show where Simeng Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Simeng Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 98 | |
| 2 | 2017 | 36 | |
| 3 | 2019 | 27 | |
| 4 | 1996 | 25 | |
| 5 | 2023 | 14 | |
| 6 | 2020 | 9 | |
| 7 | 2022 | 8 | |
| 8 | 2017 | 8 | |
| 9 | 2017 | 8 | |
| 10 | 2017 | 7 | |
| 11 | 2024 | 5 | |
| 12 | 2023 | 5 | |
| 13 | 2022 | 4 | |
| 14 | 2023 | 3 | |
| 15 | 2019 | 3 | |
| 16 | 2022 | 3 | |
| 17 | 2022 | 3 | |
| 18 | 2024 | 2 | |
| 19 | 2025 | 1 | |
| 20 | 2022 | 1 |
About Simeng Gu
Simeng Gu is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism, Cancer Research, Oncology and Pediatrics, Perinatology and Child Health, having authored 30 papers that have together received 274 indexed citations. Recurring topics across this work include Thyroid Disorders and Treatments (8 papers), Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers), Thyroid Cancer Diagnosis and Treatment (5 papers), Cancer-related gene regulation (4 papers), RNA Research and Splicing (3 papers), Epigenetics and DNA Methylation (2 papers) and Pregnancy and preeclampsia studies (2 papers). The work is most often cited by research in Cancer Research (80 citations), Obstetrics and Gynecology (30 citations), Epidemiology (75 citations), Oncology (53 citations) and Molecular Biology (114 citations). Simeng Gu has collaborated with scholars based in China, Australia and Thailand. Frequent co-authors include Mingjuan Jin, Jianbing Wang, Kun Chen, Fangyuan Jing, Kun Chen, Yingjun Li, Chunhong Fan, Qilong Li, Zhe Mo and Xiaofeng Wang. Their work appears in journals such as Nutrients, Frontiers in Oncology, Clinical Epigenetics, Gene and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.